State Street Corp Axogen, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Axogen, Inc. stock. As of the latest transaction made, State Street Corp holds 1,014,706 shares of AXGN stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,014,706

Previous 965,607 5.08%

Holding current value

$11.1 Million

Previous $15.9 Million 17.97%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$14.56 - $20.11 $714,881 - $987,380	49,099 Added 5.08%	1,014,706 $18.8 Million
Q4 2024 Feb 14, 2025	BUY	$12.47 - $17.19 $859,594 - $1.18 Million	68,933 Added 7.69%	965,607 $15.9 Million
Q3 2024 Nov 14, 2024	BUY	$7.52 - $14.69 $714,783 - $1.4 Million	95,051 Added 11.86%	896,674 $12.6 Million
Q2 2024 Aug 14, 2024	BUY	$5.67 - $8.06 $14,583 - $20,730	2,572 Added 0.32%	801,623 $5.8 Million
Q1 2024 May 15, 2024	BUY	$6.63 - $10.69 $46,171 - $74,445	6,964 Added 0.88%	799,051 $6.45 Million
Q4 2023 Feb 14, 2024	BUY	$3.61 - $7.76 $107,393 - $230,852	29,749 Added 3.9%	792,087 $5.41 Million
Q3 2023 Nov 14, 2023	SELL	$4.68 - $9.26 $745,917 - $1.48 Million	-159,384 Reduced 17.29%	762,338 $3.81 Million
Q2 2023 Aug 14, 2023	SELL	$8.5 - $10.38 $505,937 - $617,838	-59,522 Reduced 6.07%	921,722 $8.42 Million
Q1 2023 May 15, 2023	BUY	$7.53 - $10.95 $852,478 - $1.24 Million	113,211 Added 13.04%	981,244 $9.27 Million
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $311,435 - $431,852	32,991 Added 3.95%	868,033 $8.66 Million
Q3 2022 Nov 15, 2022	SELL	$8.14 - $12.25 $696,026 - $1.05 Million	-85,507 Reduced 9.29%	835,042 $9.95 Million
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $1.11 Million - $1.59 Million	-158,757 Reduced 14.71%	920,549 $7.54 Million
Q1 2022 May 16, 2022	BUY	$7.26 - $10.7 $225,553 - $332,427	31,068 Added 2.96%	1,079,306 $8.57 Million
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $670,674 - $1.22 Million	76,213 Added 7.84%	1,048,238 $9.82 Million
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $451,676 - $644,150	-29,657 Reduced 2.96%	972,025 $15.4 Million
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $324,796 - $428,804	18,247 Added 1.86%	1,001,682 $21.6 Million
Q1 2021 May 17, 2021	BUY	$17.18 - $22.6 $1.36 Million - $1.78 Million	78,904 Added 8.72%	983,435 $19.9 Million
Q4 2020 Feb 16, 2021	SELL	$11.5 - $17.96 $1.23 Million - $1.91 Million	-106,532 Reduced 10.54%	904,531 $16.2 Million
Q3 2020 Nov 10, 2020	SELL	$10.62 - $13.12 $1.84 Million - $2.28 Million	-173,467 Reduced 14.64%	1,011,063 $11.8 Million
Q2 2020 Aug 14, 2020	BUY	$7.35 - $10.81 $1.71 Million - $2.52 Million	232,835 Added 24.47%	1,184,530 $10.9 Million
Q1 2020 May 11, 2020	BUY	$8.38 - $17.34 $7.98 Million - $16.5 Million	951,695 New	951,695 $9.9 Million

Others Institutions Holding AXGN

# of Institutions

191

Shares Held

39.2M

Call Options Held

61.7K

Put Options Held

42.8K

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $462M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Axogen, Inc. Transaction History